Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have received a consensus recommendation of “Buy” from the twenty research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $91.40.

A number of research analysts recently weighed in on WBA shares. Royal Bank Of Canada started coverage on shares of Walgreens Boots Alliance in a research report on Tuesday. They set an “outperform” rating and a $96.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. Credit Suisse Group restated a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday. Finally, UBS AG restated a “buy” rating and set a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd.

TRADEMARK VIOLATION NOTICE: This story was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.dailypolitical.com/2017/09/22/analysts-set-walgreens-boots-alliance-inc-wba-pt-at-91-07.html.

Walgreens Boots Alliance (NASDAQ WBA) traded up 0.33% during trading on Friday, hitting $78.46. 3,199,596 shares of the company’s stock traded hands. The stock has a market cap of $83.96 billion, a P/E ratio of 19.81 and a beta of 1.26. The company’s 50 day moving average is $81.36 and its 200-day moving average is $81.86. Walgreens Boots Alliance has a 12 month low of $75.18 and a 12 month high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.18 earnings per share. On average, analysts predict that Walgreens Boots Alliance will post $5.00 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were paid a $0.40 dividend. The ex-dividend date was Wednesday, August 16th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.03%. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share buyback program on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 13.50% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in WBA. Franklin Resources Inc. increased its stake in shares of Walgreens Boots Alliance by 24.7% in the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Walgreens Boots Alliance by 471.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Walgreens Boots Alliance by 2.8% in the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares in the last quarter. Nordea Investment Management AB increased its stake in shares of Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after purchasing an additional 1,917,082 shares in the last quarter. Finally, Wellington Management Group LLP increased its stake in shares of Walgreens Boots Alliance by 5.9% in the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares in the last quarter. 60.16% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.